Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
European Review for Medical and Pharmacological Sciences|September 26, 2023
Factors influencing delayed discharge after day-surgery laparoscopic cholecystectomy: the DeDiLaCo study protocolN Cillara, P Fransvea, R Sechi, et al.
Clinical and Experimental Immunology|December 9, 1998
Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody statusP Invernizzi, P M Battezzati, A Crosignani, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|April 1, 2000
[The UV record. Document for quality control, therapy planning and risk assessment in dermatologic photo- and photochemotherapy]F R Ochsendorf, E M Sachsenberg-Studer, M Grundmann-Kollmann, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 30, 1996
Bile acid conjugation in early stage cholestatic liver disease before and during treatment with ursodeoxycholic acidM Fracchia, K D Setchell, A Crosignani, et al.
Hepatology (Baltimore, Md.)|September 1, 1994
Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosisM Camisasca, A Crosignani, P M Battezzati, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 22, 2001
Laparoscopy with laparoscopic ultrasound for pretreatment staging of hepatocellular carcinoma: a prospective studyM Montorsi, R Santambrogio, P Bianchi, et al.
Gut|April 25, 2006
Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosisM Allocca, A Crosignani, A Gritti, et al.
Hepatology (Baltimore, Md.)|October 1, 1992
Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response studyC Colombo, A Crosignani, M Assaisso, et al.
Gastroenterology|March 1, 1995
Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective studyM Borzio, S Bruno, M Roncalli, et al.
Italian Journal of Gastroenterology and Hepatology|February 1, 1997
Histological changes but not virus eradication reflect biochemical improvement in chronic hepatitis C patients showing a long-term response to interferon alpha therapyS Bruno, A Manzin, M Roncalli, et al.
Pageof 15